Strictly for healthcare professionals only

Online CPD
module for doctors
Evolution of
Basal Insulins and
their Role in the Management of
MAT-MY-2100732-1.0-05/2021

Type 2 Diabetes Mellitus

Brought to you by:

Sanofi-Aventis (Malaysia) Sdn. Bhd. (334110-P)

Unit TB-18-1, Level 18, Tower B, Plaza 33, No. 1, Jalan Kemajuan,
Seksyen 13, 46200 Petaling Jaya, Selangor Darul Ehsan, Malaysia.
Tel: +603 7651 0800 Fax: +603 7651 0801/0802
 Available until
7 JUNE 2022

CPD Reviewer:
Datuk Dr Zanariah Hussein
Consultant Endocrinologist
Hospital Putrajaya

Diagnoses of type 2 diabetes mellitus

are ever increasing. Newer insulin analogues and delivery systems allow for the efficient
management of diabetes and help patients achieve their target blood glucose levels.
This educational module will highlight advancements in the basal insulin therapy and
discuss the indispensable role of insulin therapy in managing diabetes.

EARN YOUR CPD POINT NOW!

Sponsored CPD for doctors: Upon successful completion of the
MAT-MY-2100732-1.0-05/2021

module, one credit point will be awarded according to Category

A7 of the CPD Credit Point System for doctors.

Sponsored as a service to

MY-SAN-316a
the medical profession by: In partnership with:
Scan to
access
Log in to register now
www.mims-cpd.com.my